Delivery Order SPE2DB22D3501-SPE2DB25FXL68
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,518.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a biologic medication used to treat systemic lupus erythematosus and lupus nephritis. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $22,357.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a monoclonal antibody treatment used for systemic lupus erythematosus. This non-competitive delivery order, issued on September 10, 2025, must be completed by October 1, 2025. The pharmaceutical supply will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key...
- The Defense Logistics Agency awarded a $10,258.92 delivery order to AmerisourceBergen Drug Corp for 400 mg vials of Benlysta, a biologic medication used to treat systemic lupus erythematosus and other autoimmune conditions. This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively...
- The Defense Logistics Agency awarded a $2,629.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with a completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,518.48 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single procurement action under the company's broader pharmaceutical supply agreement with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $15,777.72 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $7,888.86 in Benlysta 400 mg vials on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with the Defense Logistics Agency. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $10,518.48 delivery order to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,999.36 for Benlysta 400 mg vials, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to AmerisourceBergen's...